Alterity Therapeutics Ltd share price logo

Alterity Therapeutics Ltd

NASDAQ: ATHE

Small Cap

$4.54

+0.02

(+0.44%)

as on

Alterity Therapeutics Ltd Stock Performance

as on May 6, 2026 at 6:57 am IST

  • Day's Low

    Day's High

    $4.50
    $4.60
    downward going graph

    0.88%

    Downside

    1.32%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.66
    $7.00
    downward going graph

    41.41%

    Downside

    54.19%

    Upside

    downward going graph

Alterity Therapeutics Ltd share price movements today

Previous Close
$4.52
Open
$4.60
Volume
218.2K
Day's Low - High
$4.50 - $4.60
52 Week Low - High
$2.66 - $7.00

Alterity Therapeutics Ltd Historical Returns

1 Month Return
+ 25.73 %
3 Month Return
+ 28.33 %
1 Year Return
+ 9.16 %
3 Year Return
+ 49.01 %
5 Year Return
-64.05 %

Alterity Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Alterity Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$85.7M

EPS (TTM)

-0.87

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-47.03%

Alterity Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alterity Therapeutics Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Alterity Therapeutics Ltd image
Alterity Therapeutics Ltd
NA$85.7M-64.05%NA-219.85%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$40.2B127.94%75.8512.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.9B99.08%25.1832.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.1BNA120.445.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Alterity Therapeutics Ltd Stock including INR - Dollar returns

The Alterity Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Alterity Therapeutics Ltd investment value today

Current value as on today

₹1,23,655

Returns

₹23,655

(+23.65%)

Returns from Alterity Therapeutics Ltd Stock

₹9,398 (+9.4%)

Dollar Impact

₹14,257 (+14.26%)

Alterity Therapeutics Ltd Stock’s Investor Sentiment and Interest

Search interest for Alterity Therapeutics Ltd Stock has increased by 267% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:267% versus previous 30 day period

Alterity Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Total Revenue
0
1
0
1
1
2
0
1
3
Gross Profit
0
0
0
1
1
2
0
1
3
Operating Income
-3
-7
-3
-4
-6
-12
-3
-7
-7
EBITDA
-3
-7
-3
-8
-6
-14
-3
-7
-7
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-7
-3
-4
-6
-14
-3
-8
-4
Income Tax Expense
0
-1
-
-1
0
-2
-
-1
0
Net Income
-1
-3
-3
-6
-6
-12
-3
-7
-4
Net Profit Margin
-377.30%
-377.30%
-342.35%
-342.35%
-595.51%
-595.51%
-446.68%
-446.68%
-129.78%

Alterity Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
0
0
0
0
3
3
2
2
5
Gross Profit
0
0
0
0
0
3
3
2
2
5
Operating Income
-8
-6
-7
-12
-10
-15
-15
-14
-19
-14
EBITDA
-8
-6
-11
-12
-13
-15
-17
-14
-19
-14
Interest Expense
-
-
-
-
-
-
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-7
-8
-12
-10
-15
-12
-13
-19
-12
Income Tax Expense
0
0
0
0
0
-4
0
0
0
0
Net Income
-5
-5
-6
-8
-6
-11
-9
-9
-12
-12
Net Profit Margin
-5418.28%
-5696.60%
-4108.75%
-11020.84%
-2444.24%
-352.78%
-250.75%
-352.54%
-475.79%
-223.35%

Alterity Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Net Income
-
-6
-
-12
-3
-7
-
-
-9
Operating Cash Flow
0
-4
-
-8
-4
-8
-
-2
-10
Investing Cash Flow
0
0
-
0
-
-
-
-7
7
Financing Cash Flow
0
0
8
8
0
0
14
25
18
Change in Cash
0
-4
5
0
-
-4
-
15
16

Alterity Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-7
-8
-12
-10
-15
-12
-13
-19
-12
Operating Cash Flow
-5
-6
-13
-9
-17
-12
-20
-12
-11
Investing Cash Flow
0
0
0
0
0
0
0
0
-7
Financing Cash Flow
0
0
12
3
36
16
0
9
39
Change in Cash
-6
-6
0
-5
18
6
-19
-3
20

Global Institutional Holdings in Alterity Therapeutics Ltd

Funds
Holdings
Rhumbline Advisers
0%
Motiv8 Investments LLC
0%
Danske Bank A/S.
0%
UBS Group AG
0%
Ronald Blue Trust, Inc.
0%
See all

Insights on Alterity Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ATHE stock has moved up by 25.7%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ATHE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 802.96K → 3.83M (in $), with an average increase of 54.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 16.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -4.97M → -9.43M (in $), with an average decrease of 89.8% per quarter

About Alterity Therapeutics Ltd

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.
OrganisationAlterity Therapeutics Ltd
Headquarters350 Collins Street, Melbourne, VIC, Australia, 3000
IndustryBiotechnology
CEODr. David A. Stamler M.D.
E-voting on sharesClick here to vote

Key Management of Alterity Therapeutics Ltd

Name

Title

Dr. Rudolph Emile Tanzi Ph.D.

Chief Scientific Advisor and Member of Research & Development Advisory Board

Dr. Steven D. Targum M.D.

Chief Medical Advisor

Dr. Robert Cherny

Head of Research

Dr. David A. Stamler M.D.

CEO & Director

Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.

CFO & Company Secretary

FAQs

What is Alterity Therapeutics Ltd share price today?

Alterity Therapeutics Ltd share price today is $4.54 as on at the close of the market. Alterity Therapeutics Ltd share today touched a day high of $4.6 and a low of $4.5.

What is the 52 week high and 52 week low for Alterity Therapeutics Ltd share?

Alterity Therapeutics Ltd share touched a 52 week high of $7 on and a 52 week low of $2.66 on . Alterity Therapeutics Ltd stock price today i.e. is closed at $4.54,which is 35.14% down from its 52 week high and 70.68% up from its 52 week low.

What is Alterity Therapeutics Ltd's market capitalisation today?

Alterity Therapeutics Ltd market capitalisation is $0.00T as on .

How to invest in Alterity Therapeutics Ltd Stock (ATHE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alterity Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alterity Therapeutics Ltd Shares that will get you 0.3304 shares as per Alterity Therapeutics Ltd share price of $4.54 per share as on May 6, 2026 at 1:27 am IST.

What is the minimum amount required to buy Alterity Therapeutics Ltd Stock (ATHE) from India?

Indian investors can start investing in Alterity Therapeutics Ltd (ATHE) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Alterity Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Alterity Therapeutics Ltd share’s latest price of $4.54 as on May 6, 2026 at 1:27 am IST, you will get 2.2026 shares of Alterity Therapeutics Ltd. Learn more about fractional shares .

What are the returns that Alterity Therapeutics Ltd has given to Indian investors in the last 5 years?

Alterity Therapeutics Ltd stock has given -64.05% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?